DaVita Inc. $DVA Shares Sold by Knights of Columbus Asset Advisors LLC

Key Points

• Knights of Columbus Asset Advisors LLC reduced its holdings in DaVita Inc. by 58.5% during the second quarter, leaving them with 1,387 shares valued at $198,000.
• DaVita reported an earnings per share (EPS) of $2.95 for the last quarter, exceeding analysts' expectations of $2.70, while revenue rose by 6.1% year-over-year.
• Analysts have set varying target prices for DaVita, with Truist Financial at $148.00 and Bank of America lowering theirs to $140.00, reflecting a mix of view on the stock's future performance.

Knights of Columbus Asset Advisors LLC lowered its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 58.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,387 shares of the company's stock after selling 1,956 shares during the period. Knights of Columbus Asset Advisors LLC's holdings in DaVita were worth $198,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Fifth Third Bancorp grew its stake in shares of DaVita by 5.0% in the 1st quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock worth $654,000 after purchasing an additional 204 shares during the last quarter. Concurrent Investment Advisors LLC acquired a new position in shares of DaVita in the 1st quarter worth approximately $223,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of DaVita by 22.5% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company's stock worth $666,000 after purchasing an additional 800 shares during the last quarter. Envestnet Asset Management Inc. grew its stake in shares of DaVita by 7.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company's stock worth $8,452,000 after purchasing an additional 4,048 shares during the last quarter. Finally, OneDigital Investment Advisors LLC acquired a new position in shares of DaVita in the 1st quarter worth approximately $200,000. Institutional investors and hedge funds own 90.12% of the company's stock.

DaVita Stock Performance

Shares of DVA opened at $131.09 on Wednesday. The company's 50 day moving average price is $134.17 and its 200 day moving average price is $139.76. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The company has a market capitalization of $9.37 billion, a PE ratio of 12.89, a PEG ratio of 0.92 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The firm had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. During the same period in the previous year, the firm posted $2.00 earnings per share. The firm's revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DVA has been the topic of several analyst reports. Truist Financial set a $148.00 target price on shares of DaVita in a research report on Friday, August 8th. Bank of America dropped their target price on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating on the stock in a research report on Wednesday, September 10th. Weiss Ratings reissued a "hold (c+)" rating on shares of DaVita in a research report on Saturday, September 27th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research report on Saturday, September 13th. Finally, Barclays dropped their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Four investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Reduce" and an average target price of $158.00.

Insider Buying and Selling

In related news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the transaction, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company's stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.